MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$19,054K
EPS
-$0.67
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
Research and development
14,645 9,487* 2,419
General and administrative
7,459 5,179* 2,827
Total operating loss
22,104 14,666* 5,246
Interest income
2,850 1,799* 707
Realized gain on sale of marketable securities, net
0 119* 0
Loss on change in fair value of derivative instruments
200 -1,788* 983
Total non-operating income
3,050 130* 1,690
Loss before income tax
-19,054 -14,536* -3,556
Income tax provision
0 1* 0
Net loss
-19,054 -14,537 -3,556
Basic EPS
-0.67 -1.414 -0.61
Diluted EPS
-0.67 -1.414 -0.61
Basic Average Shares
28,241,701 10,283,428 5,806,862
Diluted Average Shares
28,241,701 10,283,428 5,806,862
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$19,054K Interest income$2,850K Loss on change in fairvalue of derivative...$200K Loss before incometax-$19,054K Total non-operatingincome$3,050K Total operating loss$22,104K Research and development$14,645K General andadministrative$7,459K

LB PHARMACEUTICALS INC (LBRX)

LB PHARMACEUTICALS INC (LBRX)